Blue Bear Ventures

Blue Bear Ventures invests at the earliest stages in deep technology startups built around scientific discoveries. The firm concentrates on companies emerging from top-tier research universities, primarily UC Berkeley, and deploys capital into areas including synthetic biology, novel sensors, semiconductor interconnects, and non-viral gene therapies. Its approach is thesis-driven, with technical defensibility serving as the primary underwriting criterion.

The investment team is anchored by Partners Alic Chen, Patrick Scaglia, and Marianne Abib-Pech. Alic Chen founded the CITRIS Foundry incubator at UC Berkeley and has advised or invested in 50-plus science/tech startups. Patrick Scaglia brings over 35 years of technology management experience from HP and Cadence, and serves on boards including the UC Berkeley College of Engineering. Deepak Gupta, a former Cepheid executive and molecular diagnostics entrepreneur, also contributes directly to investment decisions.

Blue Bear Ventures sources a large share of its pipeline from direct relationships with faculty and PhD founders at institutions such as UC Berkeley, UCSF, UC Santa Cruz, MIT, and Stanford. Alic Chen’s role in founding CITRIS Foundry gives the firm early visibility into applied research before startups formally raise outside capital. Its strategic partnership with BCG — Transitions First — adds a corporate demand layer to the sourcing lens, identifying startups that can solve enterprise R&D challenges.

Blue Bear Ventures typically acts as the first institutional check, often leading or co-leading pre-seed and seed rounds for university spinouts. Founder testimonials on its site indicate close and sustained involvement from incorporation onward, including support with business model refinement and follow-on fundraising. The firm’s small partnership size means a single partner usually owns each relationship across the holding period.

Transitions First is Blue Bear Ventures' strategic partnership with Boston Consulting Group, operating under the banner BBV-T1ST. It functions as a bridge between corporate R&D units and BBV's deep tech portfolio, aiming to accelerate commercialization pathways. The initiative is a structural differentiator that connects startups to enterprise adoption cycles without requiring the firm to scale its investment team.

Blue Bear Ventures concentrates on frontier science and deep technology and does not invest in consumer internet, enterprise SaaS without a hardware or biological component, or financial technology. Its portfolio is absent of mobile apps, marketplaces, or advertising-driven platforms, reflecting a deliberate exclusion of sectors where technical IP cannot act as the primary competitive moat.

The firm’s connection to UC Berkeley is operational, not merely geographic. Partner Alic Chen ran the CITRIS Foundry, UC Berkeley’s deep-tech incubator, and the partnership includes mentors at Berkeley Haas School of Business. Multiple portfolio companies — Ayar Labs, GenEdit, Correlia Biosystems, and Coreshell — originated from Berkeley labs, making the relationship a recurring feature of BBV’s sourcing and portfolio construction.